Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-352660
Filing Date
2012-08-13
Accepted
2012-08-13 17:02:15
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d350957d10q.htm 10-Q 870252
2 EX-31.1 d350957dex311.htm EX-31.1 6136
3 EX-31.2 d350957dex312.htm EX-31.2 5945
4 EX-32.1 d350957dex321.htm EX-32.1 5557
  Complete submission text file 0001193125-12-352660.txt   4693076

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20120630.xml EX-101.INS 553268
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20120630.xsd EX-101.SCH 38306
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20120630_cal.xml EX-101.CAL 48995
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20120630_def.xml EX-101.DEF 115400
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20120630_lab.xml EX-101.LAB 311624
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20120630_pre.xml EX-101.PRE 221426
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 121028309
SIC: 2835 In Vitro & In Vivo Diagnostic Substances